SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615774-17-001916
Filing Date
2017-04-28
Accepted
2017-04-28 15:12:00
Documents
9
Period of Report
2017-04-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K s105987_8k.htm 8-K 30694
2 EXHIBIT 5.1 s105987_ex5-1.htm EX-5.1 6307
3 EXHIBIT 10.1 s105987_ex10-1.htm EX-10.1 178766
4 EXHIBIT 10.2 s105987_ex10-2.htm EX-10.2 49201
5 EXHIBIT 99.1 s105987_ex99-1.htm EX-99.1 8172
6 EXHIBIT 99.2 s105987_ex99-2.htm EX-99.2 8440
7 GRAPHIC pg1img1_ex10-2.jpg GRAPHIC 6924
8 GRAPHIC pg1img1_ex99-1.jpg GRAPHIC 9787
9 GRAPHIC pg1img1_ex99-2.jpg GRAPHIC 9787
  Complete submission text file 0001615774-17-001916.txt   319691
Mailing Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049
Business Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049 310-826-5648
CYTRX CORP (Filer) CIK: 0000799698 (see all company filings)

IRS No.: 581642750 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15327 | Film No.: 17794777
SIC: 2836 Biological Products, (No Diagnostic Substances)